Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2023-11-13 Purchase | 2023-11-13 5:24 pm | Zentalis Pharmaceuticals Inc. | ZNTL | Blackwell Kimberly Chief Executive Officer | 5,000 | $10.29 | $51,448 | 254,800 (Direct) | View |
| 2022-01-03 Sale | 2022-01-05 5:49 pm | Zentalis Pharmaceuticals Inc. | ZNTL | Blackwell Kimberly Director | 1,000 | $83.74 | $83,740 | 43,000 (Direct) | View |
| 2021-12-01 Sale | 2021-12-02 7:16 pm | Zentalis Pharmaceuticals Inc. | ZNTL | Blackwell Kimberly Director | 1,000 | $81.84 | $81,840 | 44,000 (Direct) | View |
| 2021-11-01 Sale | 2021-11-02 7:24 pm | Zentalis Pharmaceuticals Inc. | ZNTL | Blackwell Kimberly Director | 1,000 | $80.46 | $80,460 | 45,000 (Direct) | View |
| 2021-10-25 Sale | 2021-10-27 8:13 pm | Zentalis Pharmaceuticals Inc. | ZNTL | Blackwell Kimberly Director | 1,000 | $77.59 | $77,590 | 46,000 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-06-20 Option Award | 2024-06-21 4:48 pm | N/A 2034-06-20 | Century Therapeutics Inc. | IPSC | Blackwell Kimberly Director | 44,000 | $0 | 44,000 (Direct) | View |
| 2024-06-12 Option Award | 2024-06-13 4:30 pm | N/A 2034-06-12 | Monte Rosa Therapeutics Inc. | GLUE | Blackwell Kimberly Director | 22,100 | $0 | 22,100 (Direct) | View |
| 2024-02-01 Option Award | 2024-02-05 7:11 pm | N/A 2034-01-31 | Zentalis Pharmaceuticals Inc. | ZNTL | Blackwell Kimberly Chief Executive Officer | 250,000 | $0 | 734,145 (Direct) | View |
| 2024-02-01 Tax Withholding | 2024-02-05 7:11 pm | N/A N/A | Zentalis Pharmaceuticals Inc. | ZNTL | Blackwell Kimberly Chief Executive Officer | 20,655 | $11.69 | 734,145 (Direct) | View |
| 2023-06-27 Option Award | 2023-06-29 4:20 pm | N/A 2024-06-27 | Century Therapeutics Inc. | IPSC | Blackwell Kimberly Director | 44,000 | $0 | 44,000 (Direct) | View |
| 2023-06-14 Option Award | 2023-06-15 4:26 pm | N/A 2033-06-13 | Monte Rosa Therapeutics Inc. | GLUE | Blackwell Kimberly Director | 20,500 | $0 | 20,500 (Direct) | View |
| 2023-02-01 Option Award | 2023-02-01 7:08 pm | N/A 2033-01-31 | Zentalis Pharmaceuticals Inc. | ZNTL | Blackwell Kimberly Chief Executive Officer | 600,000 | $0 | 605,000 (Direct) | View |
| 2022-06-15 Option Award | 2022-06-16 4:30 pm | N/A 2032-06-14 | Monte Rosa Therapeutics Inc. | GLUE | Blackwell Kimberly Director | 15,000 | $0 | 15,000 (Direct) | View |
| 2022-06-09 Option Award | 2022-06-10 4:23 pm | N/A 2032-06-09 | Century Therapeutics Inc. | IPSC | Blackwell Kimberly Director | 19,872 | $0 | 19,872 (Direct) | View |
| 2022-05-16 Option Award | 2022-05-20 4:27 pm | N/A 2032-05-15 | Zentalis Pharmaceuticals Inc. | ZNTL | Blackwell Kimberly President & CEO | 2,136,011 | $0 | 2,136,011 (Direct) | View |
| 2022-01-03 Exercise | 2022-01-05 5:49 pm | N/A 2030-06-30 | Zentalis Pharmaceuticals Inc. | ZNTL | Blackwell Kimberly Director | 1,000 | $0 | 43,000 (Direct) | View |
| 2022-01-03 Exercise | 2022-01-05 5:49 pm | N/A N/A | Zentalis Pharmaceuticals Inc. | ZNTL | Blackwell Kimberly Director | 1,000 | $47.8 | 43,000 (Direct) | View |
| 2021-12-01 Exercise | 2021-12-02 7:16 pm | N/A 2030-06-30 | Zentalis Pharmaceuticals Inc. | ZNTL | Blackwell Kimberly Director | 1,000 | $0 | 44,000 (Direct) | View |
| 2021-12-01 Exercise | 2021-12-02 7:16 pm | N/A N/A | Zentalis Pharmaceuticals Inc. | ZNTL | Blackwell Kimberly Director | 1,000 | $47.8 | 44,000 (Direct) | View |
| 2021-11-01 Exercise | 2021-11-02 7:24 pm | N/A 2030-06-30 | Zentalis Pharmaceuticals Inc. | ZNTL | Blackwell Kimberly Director | 1,000 | $0 | 45,000 (Direct) | View |
| 2021-11-01 Exercise | 2021-11-02 7:24 pm | N/A N/A | Zentalis Pharmaceuticals Inc. | ZNTL | Blackwell Kimberly Director | 1,000 | $47.8 | 45,000 (Direct) | View |
| 2021-10-25 Exercise | 2021-10-27 8:13 pm | N/A 2030-06-30 | Zentalis Pharmaceuticals Inc. | ZNTL | Blackwell Kimberly Director | 1,000 | $47.8 | 46,000 (Direct) | View |
| 2021-04-12 Option Award | 2021-06-25 5:00 pm | N/A 2031-04-12 | Monte Rosa Therapeutics Inc. | GLUE | Blackwell Kimberly Director | 54,213 | $0 | 54,213 (Direct) | View |
Ownership | 2021-06-23 8:40 pm | N/A 2030-08-13 | Monte Rosa Therapeutics Inc. | GLUE | Blackwell Kimberly Director | 0 | $0 | 35,931 (Direct) | View |
| 2021-06-17 Option Award | 2021-06-21 4:34 pm | N/A 2031-06-17 | Century Therapeutics Inc. | IPSC | Blackwell Kimberly Director | 19,872 | $0 | 19,872 (Direct) | View |
Ownership | 2021-06-17 5:07 pm | N/A 2031-05-21 | Century Therapeutics Inc. | IPSC | Blackwell Kimberly Director | 0 | $0 | 99,483 (Direct) | View |
| 2021-06-04 Option Award | 2021-06-08 5:27 pm | N/A 2031-06-03 | Zentalis Pharmaceuticals Inc. | ZNTL | Blackwell Kimberly Director | 20,000 | $0 | 20,000 (Direct) | View |
| 2020-07-01 Option Award | 2020-07-01 8:28 pm | N/A 2030-06-30 | Zentalis Pharmaceuticals Inc. | ZNTL | Blackwell Kimberly Director | 42,000 | $0 | 42,000 (Direct) | View |